In macrophages, Toll-like receptors (TLRs) activate protective immune responses, including recognition of pathogens, activation of antipathogen effector pathways and transition to protective adaptive responses 1 . Classically activated macrophages (CAMs) are important in combating infections caused by intracellular pathogens. A key antipathogen effector of CAMs is nitric oxide (NO), which is required for host control of intracellular infections, including Mycobacterium species, Toxoplasma gondii, Leishmania species and Trypanosoma cruzi 2 , and has direct antimicrobial toxicity 3 . TLR and interferon pathways synergistically trigger NO production by transcriptional and post-transcriptional mechanisms that enhance expression of inducible nitric oxide synthase (iNOS), the enzyme responsible for NO production from arginine in macrophages 2, 4, 5 . As a countermeasure, some pathogens deploy NO scavengers 6 or their own arginases 7, 8 or, in the case of Mycobacterium tuberculosis, adapt to NO made by activated macrophages 9 and exclude iNOS from phagosomes 10 . However, the mechanisms by which intracellular pathogens induce host responses that reduce or bypass NO remain largely uncharted.
Although a published report has shown that arginase activity is induced in the J774 macrophage-like cell line by infection with Mycobacterium bovis bacillus Calmette-Guérin (BCG) 11 , the isoform of arginase induced, the mechanism of induction and the biological consequences in primary macrophages and whole-animal models remain unknown. Here we report that the arginine hydrolytic enzyme arginase 1 (Arg1) was considerably induced in primary mouse macrophages by mycobacterial infection. Although macrophage Arg1 expression is commonly linked to the hypothesized antiworm functions of alternatively activated macrophages (AAMs) 12, 13 , we found that Arg1 was induced in CAMs and functioned in part to suppress NO production in intracellular infection. In whole-animal models of intracellular infection, mice lacking macrophage Arg1 expression had an advantage in terms of clearance of pathogens or survival.
RESULTS

Mycobacteria-induced Arg1 expression is STAT6 independent
Our first clue that intracellular pathogens influence host pathways to counter NO came from our observation of robust expression of the host gene encoding arginase 1 (Arg1), but not Arg2 ( Supplementary  Fig. 1 online). Arg1 protein increased over time and peaked 48 h after infection of primary mouse macrophages with M. bovis BCG (Fig. 1a) . Although Arg1 is expressed by AAMs in response to infection by extracellular pathogens such nematodes and trematodes 12, 14 , Arg1 expression has not been generally associated with intracellular infections that critically involve CAM activity. In contrast to infection with intracellular pathogens, the AAM response to extracellular pathogens does not involve iNOS, which is normally regarded as detrimental in AAM-dominated responses 15 . Instead, in AAMs, interleukin 4 (IL-4) and IL-13 stimulate host Arg1 production through the transcription factor STAT6 pathway, and AAMproduced Arg1 is hypothesized to be involved in the repair and resolution of worm-induced tissue damage 12, 13 . In determining whether the BCG-induced expression of host Arg1 was regulated through the IL-4-IL-13-STAT6 pathway, we initially reasoned that BCG infection might cause macrophages to express IL-4, IL-13 (ref. 16) or another factor that could activate STAT6. We used an assay in which we transferred supernatants from BCG-infected macrophage cultures to uninfected macrophages, then measured STAT6 phosphorylation. No factors were detectable in BCG-infected culture supernatants that could activate STAT6 phosphorylation ( Supplementary Fig. 2 online) . As STAT6 is essential for Arg1 expression in macrophages stimulated by cytokine(s) that favor AAM development 17 , we next infected bone marrow-derived macrophages (BMDMs) isolated from Stat6 -/-mice. Arg1 was induced by BCG infection to the same extent in Stat6 -/-and control BMDMs (Fig. 1a) , albeit with a slight delay in the Stat6 -/-cells.
Mycobacteria-induced Arg1 is TLR-dependent
Because BCG-induced Arg1 expression was STAT6 independent, we examined whether a pathogen-detection pathway was involved in Arg1 expression. We assessed Arg1 expression in BCG-infected macrophages lacking key components of the interferon pathway (Irf3 -/-and Ifnar -/-), the Nod1 and Nod2 signaling pathways mediated by the adaptor RIP2 (Ripk2 -/-) 18 , the inflammasome (Nlrp3 -/-and Pycard -/-) and the TLR and IL-1 pathways (Myd88 -/-and Il1r -/-). Only the adaptor molecule MyD88 was required for BCG-mediated induction of Arg1 expression ( Fig. 1b and Supplementary Fig. 3 online) . However, the MyD88-dependent pathway most likely uses TLRs, as the IL-1 receptor was not required for expression of Arg1 (Fig. 1b) . We next confirmed the mRNA findings at the protein level: in BMDMs isolated from Tlr2 -/-and Myd88 -/-mice, Arg1 expression after BCG infection was dependent mainly on MyD88 and was partially dependent on TLR2, regardless of an intact STAT6-dependent Arg1 expression pathway (Fig. 1c) . The partial function of TLR2 in Arg1 expression is consistent with the essential function for TLR2 in macrophage-mediated mycobacterial recognition and subsequent 'downstream' cytokine production 19 . Finally, we infected mice intraperitoneally with BCG and collected their spleens 10 d later. Whereas adherent splenocytes isolated from normal mice did not have detectable Arg1 express, BCG-infected mice had robust Arg1 expression, which confirmed that mycobacteria can induce Arg1 in vivo (Fig. 1d) .
The increase in macrophage Arg1 expression driven by T helper type 2 (T H 2) cytokines is controlled by an enhancer that is about 3 kilobases (kb) upstream of the basal promoter and is active in hepatocytes 20, 21 . The Arg1 enhancer binds STAT6 and other proteins, including the transcription factor C/EBPb 20, 21 . We tested whether the MyD88-dependent pathway for Arg1 expression targets the Arg1 promoter or the enhancer. In a reporter assay 21 , BCG induced expression of the Arg1 reporter only when the upstream enhancer was present (Fig. 1e) . Notably, BCG-mediated induction of Arg1 reporter activity was independent of the STAT6-binding site in the enhancer that is essential for IL-4-and IL-13-mediated Arg1 expression 21, 22 ( Supplementary Fig. 4 online).
We next considered that BCG-induced Arg1 expression could be linked to polyamine amounts in infection. Arginases supply substrate (ornithine) to ornithine decarboxylase (encoded by Odc1), the ratelimiting enzyme for polyamine synthesis. Studies have shown that Helicobacter pylori induces expression of both Arg2 and Odc1 as a means of perturbing polyamine homeostasis 23, 24 . We therefore tested the possibility that Odc1 mRNA would be increased by BCG infection as a possible mechanism for sequestration of polyamines by mycobacteria. In contrast to H. pylori infection, however, Odc1 mRNA decreased after BCG infection ( Supplementary Fig. 5a online) in a MyD88-dependent, STAT6-independent way ( Supplementary  Fig. 5b ). Collectively, our results suggest that BCG-mediated upregulation of Arg1 is unlikely to cause a greater requirement for polyamine production in our in vitro culture system.
C/EBPb is central to mycobacteria-induced Arg1
To determine the mechanisms that link the MyD88 pathway to Arg1 regulation, we focused on transcription factors that target the Arg1 enhancer. Given that the BCG-mediated increase in Arg1 expression required the upstream enhancer but not STAT6, we tested the requirement for the C/EBPb site, which is adjacent to the STAT6 site 21 . We created luciferase reporter lines in RAW macrophages in which the basal promoter (position -31 to position -2365) and promoter enhancer (position -31 to position -3810) were cloned into an insulated backbone in which the reporter was flanked by duplicated b-globin insulators 25 . We made an additional reporter line in which the C/EBPb-binding site was mutated 21 . After infection with BCG, the enhancer was required for reporter activity, consistent with the results obtained with transient transfection described above ( Fig. 2a and Supplementary Fig. 4 ). Deletion of the C/EBPb site ablated BCGmediated induction of reporter activity.
Because C/EBPb is an essential component of Arg1 induction by the IL-4-STAT6 pathway 26 , we tested whether C/EBPb is also required for Arg1 expression in mycobacterial infection. Arg1 was much less abundant in BCG-infected Cebpb -/-macrophages than in BCG-infected wild-type macrophages (Fig. 2b) . We next sought to determine whether C/EBPb expression was higher in BCG-infected macrophages. RNA blot analysis and a quantitative RT-PCR assay showed that BCG infection resulted in a four-to five-fold increase in C/EBPb mRNA in Myd88 +/+ macrophages but not in Myd88 -/-macrophages ( Fig. 2c,d ). Thus, BCG induced Arg1 expression in a STAT6-independent way that was dependent on MyD88-mediated induction of C/EBPb ( Supplementary Fig. 4 ), but both the STAT6 and MyD88 pathways of Arg1 expression required upstream regulatory elements for full activity. These data indicate the existence of two distinct pathways for inducing Arg1 expression in macrophages. One pathway described before is linked to AAM function and regulated by STAT6. Our results have identified a second pathway that is independently controlled by MyD88-dependent TLR signaling to C/EBPb and does not require STAT6.
Deletion of Arg1 in macrophages
Although AAM Arg1 is associated with antihelminth functions [13] [14] [15] , we considered the findings that pathogen arginases subvert the host's NO-based antimicrobial response 7, 8 . We hypothesized that induction of CAM Arg1 cripples CAM antimicrobial activity by hydrolyzing the substrate required for NO production. Such a mechanism would suggest that Arg1 is an essential component of the strategy used by intracellular pathogens to survive inside NO-generating macrophages. To assess the physiological importance of macrophage Arg1 expression in intracellular infection, we constructed an Arg1 conditional-knockout allele (with loxP-flanked (floxed) Arg1 (Arg1 flox/flox ); Supplementary Fig. 6 online) and used it in the deleter strain B6.129P2-Lyz2 tm1(cre)Ifo /J (transgene abbreviated here as LysMcre) to generate mice lacking Arg1 in macrophages and neutrophils (Arg1 flox/flox ; LysMcre; Supplementary Fig. 7 online) . We generated another mouse strain lacking Arg1 in all hematopoietic lineage cells using the deleter strain B6.Cg-Tg(Tek-cre)1Ywa (Tie2 now called Tek; transgene abbreviated here as Tie2cre; Fig. 3a) . We also produced a completely null mutation of Arg1 (Arg1 D/D ) that replicated the published conventional Arg1 knockout 27 . We used the Arg1 allele as a control for absolute Arg1 deficiency (Fig. 3) . As Arg1 is expressed mainly in myeloid-but not lymphoid-lineage cells 12 , the various strains provided parallel systems for testing the function of Arg1 in macrophages in vivo. Macrophages isolated from the Tie2cre intercross showed almost complete deletion of Arg1 protein and complete ablation of enzyme activity in all macrophage types tested (Fig. 3a,b) . The Arg1 flox/flox ; LysMcre mice also showed efficient deletion in BMDMs and over 80% deletion in postmitotic macrophages ( Supplementary Fig. 7 ).
Regulation of macrophage NO production in vitro requires Arg1
We first assessed whether Arg1 is an essential component of a pathway for arginine depletion that hinders macrophage NO production. We examined NO production by a substrate depletion assay that uses a defined order of cytokine stimulation to induce first Arg1 and then iNOS 28 . Applying this assay to macrophages deficient in Arg1, we found that Arg1 was essential for decreasing NO production by the substrate-depletion mechanism ( Supplementary Fig. 8 online) . Given our finding that host Arg1 expression is stimulated by intracellular pathogens, we next tested whether Arg1 influences NO synthesis in response to lipopolysaccharide (LPS) or BCG infection. After BCG infection, macrophages lacking Arg1 produced more NO (Fig. 3c) , which suggested that TLR-mediated regulation of Arg1 is a mechanism that inhibits macrophage production of NO. After stimulation with LPS, an extracellular TLR4 ligand, macrophages lacking Arg1 similarly produced more NO (Fig. 3d) , which suggested that TLR-mediated regulation of Arg1 is a common mechanism that restricts macrophage production of NO.
Loss of Arg1 benefits the host in experimental tuberculosis
Because NO is required for immune-mediated eradication of many intracellular pathogens, we next assessed the response of Arg1 flox/flox ; Tie2cre mice lacking macrophage Arg1 to M. tuberculosis infection. We first measured Arg1 expression in the lungs of M. tuberculosis-infected mice, given that human peripheral blood mononuclear cells from patients with pulmonary tuberculosis have more arginase activity 29 . In mice infected with CDC1551, a rapidly growing human isolate of M. tuberculosis, we measured the expression of iNOS, Arg1 and Arg2 in the lungs, in parallel with colony counts (Fig. 4a-d) . Whereas expression of iNOS and Arg1 mRNA increased over the course of infection, expression of Arg2 mRNA did not change during the observation period. Next we infected mice lacking macrophage Arg1 with M. tuberculosis H37Rv by the aerosol route with an inoculum of 200 bacilli. Mice lacking macrophage Arg1 had lower bacterial counts than did wild-type littermates in the lungs after the initial bacterial growth period (Fig. 4e) . We also noted lower bacterial load in the spleens of the mice lacking macrophage Arg1 at day 70 after infection (data not shown). Lung granulomas in mice lacking macrophage Arg1 occupied a smaller fraction of the total lung area (Supplementary Fig. 9 online) and were associated with a more pronounced lymphocytic infiltrate than were those of control mice (Fig. 4f) . Collectively, these data indicate that loss of macrophage Arg1 improved host control of M. tuberculosis infection.
We next assessed whether loss of Arg1 in macrophages caused higher concentrations of NO in tissues associated with mycobacterial infection. Because NO has a half-life of seconds, we used immunohistochemistry to stain nitrotyrosine as an indirect measure of the NO 'footprint' 30 . We found more nitrotyrosine staining in liver granulomas from BCG-infected mice deficient in macrophage Arg1 and in macrophage-rich areas in the lungs of tuberculosisinfected mice deficient in macrophage Arg1 than in infected control sections (Fig. 5) . We could therefore associate the loss of Arg1 in macrophages to more NO production in infected tissues in which NO is made in abundance. It is likely that higher concentrations of NO in the absence of Arg1 was one pathway that contributed to the lower colony counts in M. tuberculosis-infected Arg1 flox/flox ; Tie2cre mice.
Arg1 loss improves survival during T. gondii infection
Another intracellular pathogen that is controlled by the host NO response is T. gondii. T gondii induces NO production by macrophages, which is essential for long-term control of the infection 31, 32 . T. gondii injects rhoptry (ROP) kinases that activate host STAT proteins, including STAT6 (ref. 33) . We reasoned that Arg1 might be a target of the ROP kinases through T. gondii-mediated 'hijacking' of the STAT6 response. We therefore infected macrophages with T. gondii strain ME49 and measured STAT6 phosphorylation and Arg1 expression (Fig. 6a) . Arg1 protein expression was rapidly increased by T. gondii infection (within 1 h), but this was independent of STAT6, as Stat6 -/-macrophages had a response identical to that of wild-type cells. STAT6 tyrosine phosphorylation was induced by T. gondii as expected, but this occurred after the increase in Arg1 expression. These data confirm that like M. bovis BCG, T. gondii induces Arg1 in a STAT6-independent way.
Given the findings reported above, we next considered that T. gondii may have evolved a pathway to use host Arg1 to suppress NO production. In this scenario, mice lacking Arg1 in macrophages would have a survival advantage over control mice. We infected control mice (Arg1 flox/flox or C57BL/6 mice) or Arg1 flox/flox ; LysMcre mice with ME49 and assessed the weight and overall appearance of the mice over 7 weeks. Loss of Arg1 expression in macrophages improved host ability to combat infection with ME49. Systemic infection of C57BL/6 or Arg1 flox/flox control mice with ME49 caused a wasting disease that required the mice to be killed, whereas mice lacking macrophage Arg1 did not lose weight and did not show signs of disease (Fig. 6b) . Thus, the observations we obtained with the mycobacterial infection models can be extended to an apicomplexan intracellular parasite that also requires NO for effective immune control.
Arg1 is not essential for regulating immunity in sepsis
To determine whether the protective effects of macrophage Arg1 deletion are specific to intracellular pathogens or also occur in systemic models of infection and sepsis, we used two models of infection challenge known to systemically increase NO: LPS challenge and Streptococcus pneumoniae, which replicates extracellularly 34, 35 . We challenged mice deficient in macrophage Arg1 with LPS or with a strain of S. pneumoniae that spreads throughout the host after intranasal inoculation ( Supplementary Fig. 10 online) . In multiple experiments, control, Arg1 flox/flox ; LysMcre and Arg1 flox/flox ; Tie2cre mice showed identical survival, blood nitrates and systemic bacterial numbers ( Supplementary Fig. 10 ). Thus, macrophage Arg1 has a specific function in host susceptibility to intracellular pathogens and does not seem to affect the response to systemic infection with a Gram-positive pathogen or the response to systemic LPS administration, even though stimulation of Arg1-deficient macrophages with LPS leads to more NO (Fig. 3d) . Our data are therefore consistent with a model in which NO made during sepsis is derived mainly from sources other than macrophages 36 and does not seem to be under the control of macrophage Arg1.
DISCUSSION
CAMs are needed to control and kill mycobacteria and T. gondii, which grow in the macrophages 2 . Infected CAMs are activated by innate recognition pathways, including the TLR and interferon-g pathways, to make NO. We found that macrophage Arg1 is involved in preventing this NO production, consistent with published reports that arginases can compete with NO synthases for their common substrate, arginine 28, [37] [38] [39] . Our data suggest that in CAMs, in which NO is thought to be involved in directly killing pathogens, successful chronic infections are associated with pathogen-induced Arg1 expression, which in turn keeps NO production in check. Indeed, the absence of Arg1 was associated with more macrophage production of NO and was linked to enhanced control of mycobacteria and T. gondii. An implication of this finding is that transient interruption of macrophage Arg1 function by competitive inhibitors 40 may augment the ability of the immune system to control or eliminate intracellular pathogens such as toxoplasma and mycobacteria, which establish long-term latent infections. The products of arginase catalysis are urea and ornithine. It remains to be determined whether obligate intracellular pathogens such as M. tuberculosis 'hijack' the Arg1 pathway not only to suppress NO production but also to supply substrates for growth and survival, as has been proposed for Leishmania species, whose growth depends in part on host polyamines derived from ornithine 41 . M. tuberculosis strains made genetically deficient in urease are being tested for their ability to act as an attenuated live vaccine 42 . The function of M. tuberculosis urease is unknown, but the enzyme presumably uses urea as a substrate for production of compounds needed for survival in macrophages.
Our data have provided a possible rationale for the published finding that T. gondii injects ROP kinases that activate the host's STAT proteins 33 . It seems likely that T. gondii-activated STAT6 induces Arg1 by bypassing the IL-4 or IL-13 receptors and directly activating the Arg1 enhancer. Other toxoplasma-induced mechanisms are probably involved in Arg1 expression, as we found rapid T. gondii-induced Arg1 expression in macrophages derived from STAT6-deficient mice. T. gondii therefore uses many strategies to induce macrophage Arg1, potentially as a means of regulating exposure to NO. T. gondii induces a robust host inflammatory response that is considered essential to the parasite's ability to establish chronic infection. The production of NO from iNOS is crucial for host control of the chronic phase of toxoplasmosis 31, 32 . This is consistent with our finding that Arg1 was advantageous to the pathogen in the CAM-dependent response to T. gondii infection. Although we attribute the greater macrophage NO in the absence of Arg1 as a chief mechanism for host survival in T. gondii infection, it is possible that macrophage Arg1 has additional functions that the parasite could use as a survival strategy.
Unlike CAMs, AAMs are a distinct macrophage population that arises in polarized T H 2 responses and are not the cellular host for pathogens. AAMs are thought to be involved in immune responses associated with asthma, worm infections and pathological scenarios involving T H 2 cytokines 12-15 . In AAMs, T H 2-driven immune responses, driven by IL-4 or IL-13, induce Arg1 expression and other markers of AAM activity, such as the mannose receptor, chitinases and metalloproteinases 43 . AAM expression of Arg1 absolutely requires STAT6 (ref. 17) , and IL-4-and IL-13-mediated expression of macrophage Arg1 requires direct binding of STAT6 to an 'upstream' enhancer element in the -3-kb region of the Arg1 gene 20, 21 . However, AAMs are not known to require NO for antihelminth immunity, and AAMs do not express much iNOS. Thus, the functions of Arg1 in AAMs remain unknown.
We found that distinct mechanisms regulated Arg1 expression in different types of infections. AAMs required the functions of both STAT6 and C/EBPb but were independent of MyD88. In contrast, expression of Arg1 induced by mycobacteria was independent of the STAT6 pathway but depended on C/EBPb and MyD88. These data are consistent with studies documenting the induction of Arg1 expression by LPS 35, 44 . We speculate that the direct or indirect activation of C/EBPb by LPS is most likely responsible for the Arg1 induction in LPS-stimulated macrophages. As we found no obvious protective or pathogenic function for macrophage Arg1 in acute experimental LPS challenge, TLR-induced Arg1 has a more specific function for intracellular pathogens that require NO for their control.
Not all intracellular pathogens are killed by the NO pathway. NO has no obligate function in the clearance of chlamydia 45 , which have evolved to parasitize various cell types in diverse anatomical niches including the eye, lungs and genital tract. Notably, MyD88-dependent Arg1 expression is found in total lung homogenates in the early phase of Chlamydia pneumoniae infection 46 . The function of Arg1 in infections in which NO is not essentially required for killing remains to be determined. Our studies raise the issue of why an antipathogen response would include a component that favors intracellular pathogens. We speculate that the TLR-mediated induction of macrophage Arg1 has positive antimicrobial effector functions against other types pathogens detected by the TLR system.
METHODS
Mice. We generated a conditional Arg1 allele, complete Arg1-knockout alleles and crosses to the two deleter strains (Supplementary Methods online).
Backcrossing strategies are described in the Supplementary Methods. All mice in this study were used according to protocols approved by the Institutional Animal Care and Use Committees at St. Jude Children's Research Hospital, the National Institute of Allergy and Infectious Diseases, Colorado State University and University of Freiburg.
Macrophage isolation. BMDMs, peritoneal inflammatory macrophages and macrophages differentiated from the livers of embryonic day 14 mice were isolated and cultured as described 47 .
LPS and infectious challenge. Age-matched mice were challenged with Escherichia coli LPS as described 48 . Mice were challenged with S. pneumoniae D39X strain, modified for in vivo luciferase expression and imaged with the Xenogen IVS system as described 49 . Mice (6-8 weeks of age) were challenged intraperitoneally with M. bovis BCG Pasteur strain. For M. tuberculosis challenges, mice were infected with 200 colony-forming units of H37Rv as described 50 . Two mice were killed on day 1 for measurement of bacteria in the lungs at the initial infection. Thereafter, four or five mice of each genotype were killed at the times indicated (Fig. 6) for histological evaluation of the lungs and bacterial counts in lung and spleen homogenates. T. gondii challenges were done and evaluated as described 31 .
Enzymatic assays. Griess assays for nitrite accumulation and arginase assays were done as described 17 .
Immunoblot analysis and immunohistochemistry. Immunoblot analysis was done as described 47 . We used chicken polyclonal antibody to Arg1 (1:2,000 dilution; gift from S. Morris), rabbit polyclonal antibody to iNOS (1:5,000 dilution; 06-573; Chemicon International), mouse monoclonal antibody to iNOS (1: 1,000 dilution; C-11; sc-7271 (Santa Cruz Biotechnology) or gift from C. Nathan) and mouse monoclonal antibody to Grb2 (growth factor receptorbound protein 2; 1:2,000 dilution; 2GB04; MAB1127; Millipore). Rabbit polyclonal antibody to nitrotyrosine (AB5411; Millipore) was used for immunohistochemistry for nitrotyrosine.
In vitro macrophage BCG cocultures. BMDMs were plated in 12-well plates and were allowed to adhere overnight. Cells were washed with DMEM containing 10% (vol/vol) FCS and were incubated in a final volume of 1 ml. BCG cultures containing about 1 ml packed bacteria were washed in PBS and were sonicated in 10 ml to decrease clumping and then were diluted across a range of concentrations so that the approximate infection ratio was 100, 10 or 1 bacteria per macrophage. Infection cultures were maintained for 72-96 h, with time points for protein, RNA or NO analysis.
Statistics. We used a two-sided Student's t-test for the in vivo M. tuberculosis infection study. Survival curves were analyzed by nonparametric Kaplan-Meier statistics embedded in the Prism software package. P values less than 0.05 were considered significant in both tests.
Note: Supplementary information is available on the Nature Immunology website.
